Which statement best describes the role of the GCP in regulatory data acceptance?

• A. A patchwork of country-specific rules.
• B. A unified standard provided by the GCP guideline.
• C. Only nonbinding recommendations.
• D. Pharmacovigilance guidelines only.

Answer: (B)

The core idea here is that GCP provides a single, harmonized standard that regulators rely on to accept clinical trial data. The ICH E6 guideline brings together requirements across major regions so trials are conducted, documented, and reported in a consistent way, making data more reliably acceptable to regulators worldwide. This goes beyond being just nonbinding advice and beyond a country-by-country patchwork; many regulations reference GCP as the baseline for compliance, shaping how ethics, consent, trial conduct, data handling, monitoring, auditing, and record-keeping are managed to protect subjects and ensure data integrity. It’s not limited to pharmacovigilance—GCP covers the full scope of trial quality and ethics necessary for regulatory acceptance.